Milwaukee Journal Sentinel

Evers signs bill aimed at lowering prescripti­on drug prices.

Price negotiator­s must give state more data

- Molly Beck

MADISON - Gov. Tony Evers on Friday signed a bill that aims to lower prescripti­on drug prices in Wisconsin.

The new law adds transparen­cy requiremen­ts for pharmacy benefit managers, who manage prescripti­on drug benefits for health plans and negotiate prices for prescripti­on drugs.

The bill, introduced by Sen. Mary Felzkowski, R-Irma, and Rep. Michael Schraa, R-Oshkosh, requires the managers to give the state more informatio­n on what they pay for the drugs and whether their savings are reflected in costs paid for by customers.

The new law also bars pharmacy benefit managers from preventing customers from receiving informatio­n about cheaper alternativ­es to their prescripti­ons.

“The prescripti­on drug supply chain can be a confusing and opaque system that often sends folks jumping

“(Prescripti­on benefit managers) play a critical role in the drug supply chain and determinin­g out-of-pocket costs for patients, but frankly, they don’t have a lot of oversight or accountabi­lity.”

Gov. Evers

through hoops just to access their lifesaving medication­s. That’s just wrong. Period,” Evers said in a statement released after signing the bill in Wausau. “PBMs play a critical role in the drug supply chain and determinin­g out-ofpocket costs for patients, but frankly, they don’t have a lot of oversight or accountabi­lity.”

The plan was included in Evers’ first budget proposal but removed by Republican lawmakers during the budgetwrit­ing process.

A number of states have passed similar legislatio­n to collect informatio­n on drug prices. Most require the companies to disclose proprietar­y informatio­n on prices. That informatio­n, however, is kept confidential. The states instead disclose aggregate informatio­n.

Newspapers in English

Newspapers from United States